Contingent Consideration - Schedule of Reconciliation of Contingent Consideration Liability Related to Acquisition (Details) - USD ($) $ in Thousands	8 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Business Acquisition, Contingent Consideration [Line Items]
Change in fair value of contingent consideration		$ (4,190)	$ 4,237
Kuur Therapeutics, Inc.
Business Acquisition, Contingent Consideration [Line Items]
Beginning Balance		24,076
Ending balance, inclusive of current and non-current portion	$ 24,076	19,886	24,076
Kuur Therapeutics, Inc. | Level 3 Inputs
Business Acquisition, Contingent Consideration [Line Items]
Beginning Balance		24,076
Ending balance, inclusive of current and non-current portion	24,076	19,886	24,076
Kuur Therapeutics, Inc. | Level 3 Inputs | Fair Value, Recurring
Business Acquisition, Contingent Consideration [Line Items]
Beginning Balance	19,839	24,076
Change in fair value of contingent consideration	4,237	(4,190)
Ending balance, inclusive of current and non-current portion	$ 24,076	$ 19,886	$ 24,076